Brandon Folkes analyst CIBC

Currently out of the existing stock ratings of Brandon Folkes, 102 are a BUY (86.44%), 1 are a SELL (0.85%), 15 are a HOLD (12.71%).

Brandon Folkes

Work Performance Price Targets & Ratings Chart

Analyst Brandon Folkes, currently employed at CIBC, carries an average stock price target met ratio of 34.31% that have a potential upside of 21.1% achieved within 221 days.

Brandon Folkes’s has documented 233 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HRTX, Heron Therapeuti at 09-Jun-2025.

Wall Street Analyst Brandon Folkes

Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.

Average potential price target upside

BDSI BioDelivery Sciences International COLL Collegium Pharmaceutical EBS Emergent Biosolutions EGRX Eagle Pharmaceuticals HRTX Heron Therapeuti KIN Kindred Biosciences OPTN OptiNose TRVN Trevena VERU Veru ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC MNKD MannKind Corp IMV IMV OBSV ObsEva SA RDHL Redhill Biopharma Ltd OMER Omeros ACRX AcelRx Pharmaceuticals AMYT Amryt Pharma Holdings Ltd ANIP ANI Pharmaceuticals AXGN Axogen CERS Cerus CHMA Chiasma SPNE SeaSpine Holdings Corp VRAY ViewRay AZYO Aziyo Biologics  RANI Rani Therapeutics Holdings RMTI Rockwell Medical SMTI Sanara Medtech

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$6

$0.41 (7.33%)

$8

3 years 4 months 1 days ago
(25-Feb-2022)

1/4 (25%)

$2.17 (44.83%)

281

Hold

$5

$-0.59 (-10.55%)

3 years 4 months 12 days ago
(14-Feb-2022)

0/1 (0%)

$-0.56 (-10.07%)

Hold

$4.5

$-1.09 (-19.50%)

3 years 5 months 5 days ago
(21-Jan-2022)

4/4 (100%)

$1.14 (33.93%)

167

Buy

$6.25

$0.66 (11.81%)

$5

4 years 1 months 20 days ago
(06-May-2021)

1/2 (50%)

$3.07 (96.54%)

287

Buy

$8

$2.41 (43.11%)

5 years 7 months 13 days ago
(13-Nov-2019)

1/2 (50%)

$2.26 (36.00%)

1683

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Brandon Folkes is most bullish on?

Potential upside of $4 has been obtained for HRTX (HERON THERAPEUTI)

What Year was the first public recommendation made by Brandon Folkes?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?